Drug intelligence / Profile preview

MyoD lentiviral vector

Development stage
Preclinical
Lead developer
University of Ferrara
Modality
Gene Therapies
Administration
In Vitro
01

Overview

MyoD lentiviral vector is a gene therapy research tool designed to deliver the MYOD1 (Myoblast Determination Protein 1) gene into non-muscle cells, such as fibroblasts and urinary stem cells (USCs). MYOD1 is a master transcriptional regulator that initiates the skeletal muscle differentiation program. By overexpressing this factor, the vector induces myogenic reprogramming, converting target cells into myoblasts and multinucleated myotubes in vitro. This technology is primarily utilized to create patient-specific cellular models for neuromuscular disorders, most notably Duchenne muscular dystrophy (DMD). These models allow researchers to investigate disease mechanisms and evaluate the efficacy of therapeutic candidates, such as antisense oligonucleotides, without the need for invasive muscle biopsies.

Other names
MYOD1 lentiviral vectorMYOD-1 lentiviral vectorMYOD 1 lentiviral vectorMyoD-expressing lentiviruslentivirus-mediated MYOD1
02

Targets

DNA

Beyond the preview

Go deeper on MyoD lentiviral vector.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyoD lentiviral vector.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call